Recent Articles

Clovis Oncology (CLVS) Knocked Out By FDA Inquiry

Clovis Oncology Inc suffered a massive setback to its lung cancer treatment program, erasing years of gains made by CLVS stock. More 

These 51 Blue Chip Stocks Are On the Move

Having updated information on stocks is a key to investment success. Get started with updated rating on these 51 Blue Chip stocks More 

How to Play 62 Stock Upgrades and Downgrades Today

During these times, it pays to stay on top of the latest profit opportunities. Today's blog post highlights 62 stocks to buy, sell, or hold. More 

AZN, ZSPH: AstraZeneca to Buy ZS Pharma for $2.7B

AZN has announced that it's planning to buy ZS Pharma for $2.7 billion in a deal that is expected to close by the end of 2015. More 

AstraZeneca (AZN) Gets Bad News About Diabetes Drug Combo

AstraZeneca's diabetes drug combo has been delayed after it was denied by the U.S. Food and Drug Administration due to a lack of data. More 

Biggest Movers in Healthcare Stocks Now – PCRX CRL PBH ZIOP

Healthcare stocks rose 0.5% on Wall Street on Friday. More 

Biggest Movers in Healthcare Stocks Now – PCRX AGN SIRO UTHR

Healthcare stocks finished up 0.3% on Wall Street on Thursday. More